BNOX
Bionomics Ltd ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Generic
- Website bionomics.com.au
- Employees(FY) -
- ISIN US09063M2052
Performance
-13.41%
1W
-16.83%
1M
-32.53%
3M
-35.88%
6M
-43.24%
YTD
-62.16%
1Y
Profile
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. The company has a collaboration with Merck & Co., Inc. to identify novel a7 Nicotinic Acetylcholine Receptor PAMs suitable for the treatment of cognitive disorder. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.
Technical Analysis of BNOX 2024-05-10
Overview:
In analyzing the technical indicators for BNOX over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights...
Recent News & Updates
- 2023-02-24 02:05
- 2023-02-22 17:00
Bionomics Half-Year Report(Yahoo Finance)
- 2023-02-05 06:02
Will Bionomics (ASX:BNO) Spend Its Cash Wisely?(Yahoo Finance)
- 2023-01-30 05:23
Quarterly Activities and Cashflow Report(Yahoo Finance)
- 2022-12-19 02:29
- 2022-12-18 20:30
- 2022-12-18 06:34
- 2022-12-15 05:35
- 2022-12-01 17:00
- 2022-11-21 05:13
- 2022-11-16 05:36
- 2022-11-01 18:00
- 2022-10-24 18:00
Quarterly Activities Report for September 2022(Yahoo Finance)
- 2022-10-17 18:00
- 2022-10-07 04:39
- 2022-10-03 18:00
- 2022-09-20 18:00
- 2022-09-14 21:55
- 2022-08-30 18:00
- 2022-08-29 21:55
- 2022-08-27 06:26
We're Keeping An Eye On Bionomics' (ASX:BNO) Cash Burn Rate(Yahoo Finance)
- 2022-08-24 18:00
Bionomics reports Full Year Financial Results(Yahoo Finance)
- 2022-08-07 18:00
- 2022-07-28 18:00
Quarterly Activities Report for June 2022(Yahoo Finance)
- 2022-07-07 18:00
- 2022-06-26 18:00
- 2022-06-23 19:44
- 2022-06-13 04:30
Bionomics Investor Webinar(Yahoo Finance)
- 2022-05-15 18:00
- 2022-05-09 20:00